Blog
RSS FeedPosted by Michael Wonder on 28 Nov 2018
Drug makers gain more access to China, but at a price
28 November 2018 - Regulators have green-lighted dozens of outside drugs for use in China over the past 21 months, ...
Posted by Michael Wonder on 27 Nov 2018
Pharma agrees to 2 percent cap on branded meds growth
25 November 2018 - The Association of the British Pharmaceutical Industry has agreed the terms of the 2019 Pharmaceutical Price ...
Posted by Michael Wonder on 26 Nov 2018
UK pharma industry reacts to outcome of European Council meeting
25 November 2018 - The European Council has endorsed the Agreement on the withdrawal of the UK from the EU and ...
Posted by Michael Wonder on 19 Nov 2018
Pharma ignores the squabbling and prepares for a hard Brexit
19 November 2018 - Costs are irrecoverable in industry that has to plan for all possible scenarios. ...
Posted by Michael Wonder on 17 Nov 2018
BHA, ABPI welcome UK’s EU withdrawal agreement
16 November 2018 - The Brexit Health Alliance has welcomed the agreement on the terms of the UK’s withdrawal from ...
Posted by Michael Wonder on 15 Nov 2018
Lowering the price of new drugs comes with too high a cost — Canadians' health
14 November 2018 - Ottawa wants to apply new price regulations, which will only cut manufacturer profits and deter the introduction ...
Posted by Michael Wonder on 15 Nov 2018
Disclosing prescription-drug prices in advertisements — legal and public health issues
14 November 2018 - On October 15, 2018, the CMS proposed a rule requiring television advertisements for prescription drugs and ...
Posted by Michael Wonder on 10 Nov 2018
AstraZeneca chief says the US drugs market is under pressure and changes are coming
8 November 2018 - Pascal Soriot, the CEO of European pharma giant AstraZeneca, believes that now the Democrats have won back ...
Posted by Michael Wonder on 09 Nov 2018
Lilly snaps up regulatory 'fast pass' for bargain price
2 November 2018 - Priority review vouchers used to be highly sought: back in 2015, for example, AbbVie paid United ...
Posted by Michael Wonder on 06 Nov 2018
Pharma makes lobbying push to roll back seniors' drug discounts
6 November 2018 - Drug industry stands to lose $1.9 billion under February law. ...
Posted by Michael Wonder on 31 Oct 2018
Pfizer CEO: 'Business as normal' on drug prices next year despite Trump pressure
30 October 2018 - Pfizer CEO Ian Read said the company will return to “business as normal” on its drug ...
Posted by Michael Wonder on 30 Oct 2018
Pharma's support of Trump's drug pricing plan is fraying heading into midterms
30 October 2018 - Allergan CEO Brent Saunders called the plan a "dangerous proposition" in a recent interview. ...
Posted by Michael Wonder on 29 Oct 2018
PhRMA statement on HHS speech and Part B proposal
25 October 2018 - Pharmaceutical Research and Manufacturers of America President and CEO Stephen J. Ubl issued the following statement. ...
Posted by Michael Wonder on 29 Oct 2018
Health Secretary warns pharma: administration will push ahead with drug pricing reforms
26 October 2018 - Health and Human Services Secretary Alex Azar said Friday he would push ahead with drug pricing ...
Posted by Michael Wonder on 28 Oct 2018
Drug lobby compares Trump drug price plan to ‘socialised’ system
26 October 2018 - The lobbying groups for U.S. drugmakers aren’t happy about President Donald Trump’s plan to borrow from ...